Deficiency of pyruvate dehydrogenase caused by novel and known mutations in the E1alpha subunit
- PMID: 15384102
- DOI: 10.1002/ajmg.a.30287
Deficiency of pyruvate dehydrogenase caused by novel and known mutations in the E1alpha subunit
Abstract
Pyruvate dehydrogenase (PDH)-complex deficiency (OMIM 312170) is a clinically heterogeneous disorder, with phenotypes ranging from fatal lactic acidosis (LA) in the newborn to chronic neurological dysfunction. To date, over 80 different mutations have been identified in the PDHA1 gene in patients with PDH complex deficiency, which are thus thought to contribute to the PDH deficient phenotype. We have identified 14 additional patients with total PDH complex deficiency, all of whom were found to contain mutations within the PDHA1 gene (E(1)alpha subunit). The mutations include both missense mutations and duplications. Eight of these patients had novel mutations, and the remaining had mutations that have been identified previously in PDH complex deficient patients, with residual fibroblast activity ranging from 2.4 to 69% of control values. The nature of these mutations illustrates the variability in phenotype for a given gene defect, with intermittent ataxia being the mildest presentation, Leigh syndrome being the most common and severe neonatal LA the most severe.
(c) 2004 Wiley-Liss, Inc.
Similar articles
-
Four novel PDHA1 mutations in pyruvate dehydrogenase deficiency.J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S235-9. doi: 10.1007/s10545-009-1179-8. Epub 2009 Jun 11. J Inherit Metab Dis. 2009. PMID: 19517265
-
Somatic mosaicism for PDHA1 mutation in a male with pyruvate dehydrogenase complex deficiency.Mol Genet Metab. 2010 Jul;100(3):296-9. doi: 10.1016/j.ymgme.2010.04.004. Epub 2010 Apr 14. Mol Genet Metab. 2010. PMID: 20462777
-
Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency.Hum Mutat. 2000;15(3):209-19. doi: 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.0.CO;2-K. Hum Mutat. 2000. PMID: 10679936 Review.
-
Molecular characterization of 82 patients with pyruvate dehydrogenase complex deficiency. Structural implications of novel amino acid substitutions in E1 protein.Mol Genet Metab. 2011 Dec;104(4):507-16. doi: 10.1016/j.ymgme.2011.08.008. Epub 2011 Aug 18. Mol Genet Metab. 2011. PMID: 21914562
-
Pyruvate dehydrogenase complex deficiency and its relationship with epilepsy frequency--An overview.Epilepsy Res. 2015 Oct;116:40-52. doi: 10.1016/j.eplepsyres.2015.07.002. Epub 2015 Jul 8. Epilepsy Res. 2015. PMID: 26354166 Review.
Cited by
-
Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency.Eur J Pediatr. 2006 Jul;165(7):462-6. doi: 10.1007/s00431-006-0104-5. Epub 2006 Mar 22. Eur J Pediatr. 2006. PMID: 16552546
-
The in-depth evaluation of suspected mitochondrial disease.Mol Genet Metab. 2008 May;94(1):16-37. doi: 10.1016/j.ymgme.2007.11.018. Epub 2008 Feb 1. Mol Genet Metab. 2008. PMID: 18243024 Free PMC article. Review.
-
Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencing.Mol Genet Metab Rep. 2016 Apr 18;7:70-6. doi: 10.1016/j.ymgmr.2016.03.004. eCollection 2016 Jun. Mol Genet Metab Rep. 2016. PMID: 27144126 Free PMC article.
-
Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers.Oncotarget. 2017 Feb 21;8(8):13344-13356. doi: 10.18632/oncotarget.14527. Oncotarget. 2017. PMID: 28076853 Free PMC article.
-
Clinical manifestations in two patients with pyruvate dehydrogenase deficiency and long-term survival.Hum Genome Var. 2017 Jun 1;4:17020. doi: 10.1038/hgv.2017.20. eCollection 2017. Hum Genome Var. 2017. PMID: 28584645 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources